DE1543549A1 - Verfahren zur Herstellung einer Komplexverbindung aus Propoxyphen und Salicylsaeure - Google Patents
Verfahren zur Herstellung einer Komplexverbindung aus Propoxyphen und SalicylsaeureInfo
- Publication number
- DE1543549A1 DE1543549A1 DE19661543549 DE1543549A DE1543549A1 DE 1543549 A1 DE1543549 A1 DE 1543549A1 DE 19661543549 DE19661543549 DE 19661543549 DE 1543549 A DE1543549 A DE 1543549A DE 1543549 A1 DE1543549 A1 DE 1543549A1
- Authority
- DE
- Germany
- Prior art keywords
- propoxyphene
- salicylic acid
- complex
- complex compound
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 title claims description 36
- XLMALTXPSGQGBX-GCJKJVERSA-N dextropropoxyphene Chemical compound C([C@](OC(=O)CC)([C@H](C)CN(C)C)C=1C=CC=CC=1)C1=CC=CC=C1 XLMALTXPSGQGBX-GCJKJVERSA-N 0.000 title claims description 20
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 title claims description 18
- 229960004889 salicylic acid Drugs 0.000 title claims description 18
- 229960004193 dextropropoxyphene Drugs 0.000 title claims description 16
- 238000000034 method Methods 0.000 title claims description 7
- 150000001875 compounds Chemical class 0.000 title description 14
- 238000002360 preparation method Methods 0.000 title description 2
- 239000000203 mixture Substances 0.000 claims description 8
- 229960003221 levopropoxyphene Drugs 0.000 claims description 4
- 238000002425 crystallisation Methods 0.000 claims description 3
- 230000008025 crystallization Effects 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 238000002844 melting Methods 0.000 claims description 3
- 230000008018 melting Effects 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 239000002253 acid Substances 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229960001948 caffeine Drugs 0.000 description 2
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- CPJSUEIXXCENMM-UHFFFAOYSA-N phenacetin Chemical compound CCOC1=CC=C(NC(C)=O)C=C1 CPJSUEIXXCENMM-UHFFFAOYSA-N 0.000 description 2
- 229960001860 salicylate Drugs 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 101000973623 Homo sapiens Neuronal growth regulator 1 Proteins 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 241001026509 Kata Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 102100022223 Neuronal growth regulator 1 Human genes 0.000 description 1
- 241001122767 Theaceae Species 0.000 description 1
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical compound ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 1
- 210000003489 abdominal muscle Anatomy 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- HQABUPZFAYXKJW-UHFFFAOYSA-N butan-1-amine Chemical compound CCCCN HQABUPZFAYXKJW-UHFFFAOYSA-N 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- PCHPORCSPXIHLZ-UHFFFAOYSA-N diphenhydramine hydrochloride Chemical compound [Cl-].C=1C=CC=CC=1C(OCC[NH+](C)C)C1=CC=CC=C1 PCHPORCSPXIHLZ-UHFFFAOYSA-N 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 239000004081 narcotic agent Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229940124641 pain reliever Drugs 0.000 description 1
- 210000004197 pelvis Anatomy 0.000 description 1
- 229960003893 phenacetin Drugs 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C65/01—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
- C07C65/03—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups monocyclic and having all hydroxy or O-metal groups bound to the ring
- C07C65/05—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups monocyclic and having all hydroxy or O-metal groups bound to the ring o-Hydroxy carboxylic acids
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Biological Depolymerization Polymers (AREA)
- Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
- Filling Or Discharging Of Gas Storage Vessels (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US48292465A | 1965-08-26 | 1965-08-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE1543549A1 true DE1543549A1 (de) | 1969-09-25 |
Family
ID=23917960
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19661543549 Pending DE1543549A1 (de) | 1965-08-26 | 1966-08-26 | Verfahren zur Herstellung einer Komplexverbindung aus Propoxyphen und Salicylsaeure |
Country Status (10)
| Country | Link |
|---|---|
| BE (1) | BE686063A (enrdf_load_html_response) |
| BR (1) | BR6682364D0 (enrdf_load_html_response) |
| CH (1) | CH477402A (enrdf_load_html_response) |
| DE (1) | DE1543549A1 (enrdf_load_html_response) |
| ES (1) | ES330534A1 (enrdf_load_html_response) |
| FR (1) | FR5690M (enrdf_load_html_response) |
| GB (1) | GB1124686A (enrdf_load_html_response) |
| IL (1) | IL26385A (enrdf_load_html_response) |
| NL (1) | NL6612078A (enrdf_load_html_response) |
| NO (1) | NO117859B (enrdf_load_html_response) |
-
1966
- 1966-08-24 IL IL2638566A patent/IL26385A/xx unknown
- 1966-08-24 NO NO16441966A patent/NO117859B/no unknown
- 1966-08-24 ES ES0330534A patent/ES330534A1/es not_active Expired
- 1966-08-25 BR BR18236466A patent/BR6682364D0/pt unknown
- 1966-08-26 BE BE686063D patent/BE686063A/xx unknown
- 1966-08-26 FR FR74232A patent/FR5690M/fr not_active Expired
- 1966-08-26 CH CH1238466A patent/CH477402A/de unknown
- 1966-08-26 DE DE19661543549 patent/DE1543549A1/de active Pending
- 1966-08-26 GB GB3847166A patent/GB1124686A/en not_active Expired
- 1966-08-26 NL NL6612078A patent/NL6612078A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CH477402A (de) | 1969-08-31 |
| NL6612078A (enrdf_load_html_response) | 1967-02-27 |
| FR5690M (enrdf_load_html_response) | 1968-01-08 |
| BR6682364D0 (pt) | 1973-11-13 |
| NO117859B (enrdf_load_html_response) | 1969-10-06 |
| BE686063A (enrdf_load_html_response) | 1967-02-27 |
| IL26385A (en) | 1970-04-20 |
| GB1124686A (en) | 1968-08-21 |
| ES330534A1 (es) | 1967-06-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3019350C2 (enrdf_load_html_response) | ||
| DE2501787C2 (enrdf_load_html_response) | ||
| DE69218557T2 (de) | Stabile Zusammensetzung die ein Enalapril-Salz enthält, Verfahren zu ihrer Herstellung und ihre Verwendung | |
| DE3434707A1 (de) | Nicht-ulcerogene pharmazeutische zusammensetzungen mit entzuendungshemmender und/oder schmerzstillender wirksamkeit | |
| DE2036114B2 (de) | Wäßriges Tetramisolpräparat | |
| DE1793646C3 (de) | Glyoxyldithiosemicarbazone Ausscheidung aus 1518228 | |
| DE2362958A1 (de) | N-substituiertes pyridon und verfahren zur herstellung von pyridon-verbinnungen | |
| DE2103387C3 (de) | Verwendung des Hydrochlorids von Glukosamin zur Herstellung von pharmazeutischen Präparaten | |
| DE3130912A1 (de) | Analgetische arzneimittelkombination | |
| DE1543549A1 (de) | Verfahren zur Herstellung einer Komplexverbindung aus Propoxyphen und Salicylsaeure | |
| DE1043587B (de) | Verfahren zur Herstellung eines Appetitzueglers | |
| DE1667902C3 (de) | Per oral verabreichbare Zubereitungen zur Bekämpfung der Seborrhoe | |
| DE3414049C2 (enrdf_load_html_response) | ||
| DE2931319A1 (de) | 6-methoxy-2-acetylnaphthalinoxim- derivate, verfahren zu ihrer herstellung sowie sie enthaltende arzneimittel | |
| DE550833C (de) | Verfahren zur UEberfuehrung von Bakterienpraeparaten, Bakterienextrakten, Toxinen, Sera u. dgl. in haltbare, die Haut und die Schleimhaeute leicht durchdringende Produkte | |
| DE1620177B2 (de) | N-(2-Hydroxyäthyl) -piperazinocarboxymethyl-te tr acy elin, dessen pharmakologisch verwendbaren Salze, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel | |
| DE3879966T2 (de) | Kalziumchlorid enthaltende zubereitung bei der vorbeugung und behandlung von hypocalcaemie bei wiederkaeuern. | |
| DE1795745C3 (de) | Arzneimittel, enthaltend 5-substituierte 4-Aza-dibenzocycloheptene | |
| DE2532180C2 (de) | Verwendung von Etozolin bei der Bekämpfung der Hypertonie | |
| DE900378C (de) | Verfahren zur Herstellung therapeutisch hochwirksamer gut resorbierbarer Substanzen geringer Reizwirkung | |
| DE2059620A1 (de) | Neuartige Aminoaethansulfonsaeurederivate | |
| DE1617731A1 (de) | Pharmazeutische Praeparate | |
| DE2245826C3 (de) | Salze von N-Cyano-äthyl-N'-m-chlorphenyl-piperazin | |
| DE1793769B1 (de) | Verfahren zur herstellung von bis-(thiosemicarbazonen) | |
| DE2408372A1 (de) | Pharmazeutische zubereitungen auf der grundlage von hippursaeurederivaten |